Engineered nucleases, compositions, and methods of use thereof
US12054756B2 · kind B2 · utility
0Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2023 |
| Grant date | Aug 6, 2024 |
| Priority date | — |
| Expiry date | Jul 7, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/20
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides one or more engineered nucleases and systems, compositions, and methods thereof, wherein the one or more engineered nucleases can be used to effect binding, cleaving, and/or editing a target polynucleotide sequence. The one or more engineered nucleases can be engineered variants of a small CRISPR/Cas protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.